Session 4 of Young Investigator Symposium
8 January 2025
A PVRI 2024 Digital webinar
8 January 2025, 3pm GMT
The Young Investigators Series aims to showcase the groundbreaking research being done by clinicians and scientists that are early in their careers. Sessions will be divided to focus on clinical research or basic science translational research. The PVRI Leadership has the goal to be inclusive, to support, and to highlight the work being done by individuals in the pulmonary vascular research field, including its newest and youngest members.
Presentations
- Scientific networks bridging pathogens and pulmonary vascular disease Suellen Oliveira, University of Illinois
- Inflammasome activation in pulmonary arterial hypertension Neil Goldenberg, University of Toronto
- CXCL12, endothelial cell metabolism, and endothelial proliferation in pulmonary arterial hypertension Imad Al Ghouleh, Brown University and Brown University Health
- Targeting neuroinflammation as a novel therapeutic strategy for pulmonary arterial hypertension and right heart failure Soban Umar, University of California
- Spironolactone: an old drug with new tricks? Jason Elinoff, National Institutes of Health
- HIPPO/MST signaling via BUB3 and FOXO drives pulmonary vascular cell growth and survival Tatiana Kudryashova, University of Pittsburgh
Moderated by Tim Lahm, National Jewish Health and Vinicio de Jesus Perez, Stanford University
Speakers & moderators
Suellen Oliveira, University of Illinois, USA
Neil Goldenberg, University of Toronto, Canada
Imad Al Ghouleh, Brown University, USA
Soban Umar, University of California, USA
Jason Elinoff, National Institutes of Health, USA
Tatiana Kudryashova, University of Pittsburgh, USA
Tim Lahm, National Jewish Health, USA
Vinicio de Jesus Perez, Stanford University, USA
Additional comments are available to members. Login or register to become a member today
RegisterorLogin to view